Possible role of proinflammatory cytokines in heart allograft coronary artery disease

American Journal of Cardiology

Volumn 84, Issue 9, 1999, Pages 999-1003

  Gullestad, Lars ^a   Simonsen, Svein ^a   Ueland, Thor ^a   Holm, Torbjørn ^a   Aass, Halfdan ^a   Andreassen, Arne K ^a   Madsen, Steinar ^a   Geiran, Odd ^a   Frøland, Stig S ^a   Aukrust, Pål ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETA CHEMOKINE; CYCLOSPORIN A; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RECIPIENT;

ADULT; AGED; CHEMOKINE CCL2; CHOLESTEROL, LDL; CORONARY DISEASE; CYTOKINES; FEMALE; HEART TRANSPLANTATION; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032729005     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00487-7     Document Type: Article

References (26)

1. Gallo P., Agozzino L., Angelini A., Arbustini E., Bartolini G., Bernucci P., Bonacina E., Bosman C., Catani G., di Gioia, et al. Causes of late failure after heart transplantation a ten-year survey . J Heart Lung Transplant. 16:1997;1113-1121.
2. Costanzo M.R., Naftel D.C., Pritzker M.R., Heilman J.K. III, Boehemer J.P., Brozena S.C., Dec G.W., Ventura H.O., Kirklin J.K., Bourge R.C., Miller L.W. Heart transplant coronary artery disease detected by coronary angiography a multiinstitutional study of preoperative donor and recipient risk factors . J Heart Lung Transplant. 17:1998;744-753.
3. Weis M., von Scheidt W. Cardiac allograft vasculopathy. Circulation. 96:1997;2069-2077.
4. Baan C.C., Holweg C.T.J., Niesters H.G.M., van Gelder T., Mol W.M., Zondervan P.E., Balk A.H.M.M., Weimar W. The nature of acute rejection is associated with development of graft vascular disease after clinical heart transplantation. J Heart Lung Transplant. 17:1998;363-373.
5. Mehar MR, Ventura HO, Chambers RB, Ramireddy K, Smart FW, Stapelton DD. The prognostic impact of immunosuppression and cellular rejection of cardiac allograft vasculopathy: time for a reappraisal. J Heart Lung Transplant 1997;16:743-731.
6. Grattan M.T., Moreno-Cabral C.E., Starnes V.A., Oyer P.E., Stinson E.B., Shumway N.E. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 261:1989;3561-3566.
7. Salomon R.N., Hughes C.C., Schoen F.J., Payne D.D., Pober J.S., Libby P. Human coronary transplantation-associated atherosclerosis evidence for a chronic immune reaction in activated graft endothelial cells . Am J Pathol. 138:1991;791-798.
8. Shi C., Lee W.S., He Q., Zhang D., Fletcher D.L., Newell J.B. Jr, Haber E. Immunologic basis of transplant-associated atherosclerosis. Proc Natl Acad Sci USA. 93:1996;4051-4056.
9. Nagano H., Mitchell R.N., Taylor M.K., Hasegawa S., Tilney N.L., Libby P. Interferon-γ deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest. 100:1997;500-507.
10. Molossi S., Clausell N., Sett S., Rabinovitch M. ICAM-1 and VCAM-1 expression in accelerated cardiac allograft arteriopathy and myocardial rejection are influenced differently by cyclosporine A and tumor necrosis factor-α blockade. J Pathol. 176:1995;175-182.
11. Russell M.E., Adams D.H., Wyner L.R., Yamashita Y., Halnon N.J., Karnovsky M.J. Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allograft. Proc Natl Acad Sci USA. 90:1993;6086-6090.
12. van Besow N.M., Daane C.R., Vaessen L.M., Mochtar B., Balk A.H., Weimar W. Donor-specific cytokine production by graft-infiltrating lymphocytes induces and maintains graft vascular diseases in human cardiac allografts. Transplantation. 63:1997;1313-1318.
13. Libby P. Atheroma more than mush . Lancet. 348:(suppl. 1):1996;S4-S7.
14. Aukrust P., Ueland T., Lien E., Bendtzen K., Müller F., Andreassen A.K., Nordøy I., Aass H., Espevik T., Simonsen S., Frøland S.S., Gullestad L. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 83:1999;376-382.
15. Kemma M.S., Valantine H.A., Hunt S.A., Schroeder J.S., Chen Y.-D., Reaven G.M. Metabolic risk factors for atherosclerosis in heart transplant recipients. Am Heart J. 128:1994;68-72.
16. Hosenpud J.D., Shipley G.D., Wagner C.R. Cardiac allograft vasculopathy current concepts, recent developments, and future direction . J Heart Lung Transplant. 11:1992;9-23.
17. Koglin J., Glysing-Jensen T., Räisänen-Sokolowski A., Russell M.E. Immune sources of transforming growth factor-β1 reduce transplant arteriosclerosis. Circ Res. 83:1998;652-660.
18. Young J.B., Lloyd K.S., Windsor N.T., Cocanougher B., Weilbaecher D.G., Kleiman N.S., Smart F.W., Nelson D.L., Lawrence E.C. Elevated soluble interleukin-2 receptor levels early after heart transplantation and long-term survival and development of coronary arteriopathy. J Heart Lung Transplant. 10:1991;243-250.
19. Cushing S.D., Berliner J.A., Valente A.J., Territo M.C., Navab M., Parhami F., Gerrity R., Schwartz C.J., Fogelmann A.M. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA. 87:1990;5134-5138.
20. Brand K., Page S., Rogler G., Bartsch A., Brandl R., Knueschel R., Page M., Kaltschmidt C., Baeuerle P.A., Neumeier D. Activated transcriptional factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest. 97:1996;1715-1722.
21. Sukovich D.A., Kauser K., Shirley F.D., DelVecchio V., Halks-Miller M., Rubanyi G.M. Expression of interleukin-6 in atherosclerotic lesions of male ApoE-knockout mice. Arterioscler Thromb Vasc Biol. 18:1998;1498-1505.
22. Russell M.E., Wallace A.F., Hancock W.W., Sayegh M.H., Adams D.H., Sibinga N.E., Wyner L.R., Karnovsky M.J. Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation. 59:1995;572-578.
23. Jovinge S., Hamsten A., Tornvall P., Proudler A., Båvenholm P., Ericsson C.-G., Godsland I., de Faire U., Nilsson J. Evidence for the role of tumor necrosis factor α in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease. Metabolism. 47:1998;113-118.
24. Jovinge S., Ares M.P.S., Kallin B., Nilsson J. Human monocytes/macrophages release TNF-α in response to Ox-LDL. Arterioscler Thromb Vasc Biol. 16:1996;1573-1579.
25. Terkeltaub R., Banka C.L., Solan J., Santoro D., Brand K., Curtiss U.K. Oxidized LDL induces monocyte cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. Arterioscler Thromb. 14:1994;47-53.
26. Alonso D.R., Starek P.K., Minick C.R. Studies on the pathogenesis of atherosclerosis induced in rabbit cardiac allografts by the synergy of graft rejection and hypercholesterolemia. Am J Pathol. 87:1977;415-434.